SNo Title of the Paper Status of Publication Download
1 Isolation and characterization of the new SARS-CoV-2 variant in travellers from the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage Published in Journal of Travel Medicine
Oxford University Press
2 Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2 Published in Journal of Travel Medicine
Oxford University Press
3 Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travellers from South Africa and Tanzania to India Published in Travel Medicine & Infectious Diseases
Elsevier, Netherlands
4 An epidemiological analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India Published in Viruses
MDPI, Switzerland
5 Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees Published in Clinical Infectious Diseases
6 Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccine Published in Journal of Travel Medicine
7 Comparison of SARS-CoV-2 VOC 202012/01 (UK variant) and D614G variant transmission by different routes in Syrian hamsters Published in Vector Borne & Zoonotic Diseases
Mary Ann Liebert, Inc. Publishers, USA
8 Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1 Accepted in Clinical Infectious Diseases
Oxford University Press
9 Detection of SARS-CoV-2 variants in India from UK returnees Accepted in Infection
Springer, Germany
10 SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variant Under review in Clinical Infectious Diseases
Released on BioRxiv
11 Comparison of the pathogenicity and virus shedding of SARS CoV-2 VOC 202012/01 and D614G variant in hamster model Under review in Scientific reports
Released on BioRxiv
12 Isolation and characterization of SARS-CoV-2 VOC, 20H/501Y.V2, from UAE travellers Under review in Travel Medicine & Infectious Diseases
Released on BioRxiv
13 Possible role of accessory proteins in the viral replication for the 20I/501Y.V1 (B.1.1.7) SARS-CoV-2 variant Published in Pathogens
MDPI, Switzerland
14 Isolation of SARS-CoV-2 B.1.1.28.2 P2 variant and pathogenicity comparison with D614G variant in hamster model Published in Journal of Infection and Public Health
15 Detection of SARS CoV-2 VUI-202102/03 variant (B.1.525) from India. Under review in Indian Journal of Medical Research
16 Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin Published in Journal of Travel Medicine
17 Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19 recovered vaccinated individuals Published in Journal of Travel Medicine
Oxford University Press
18 Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/COVAXIN Published in Journal of Travel Medicine
Oxford University Press
19 Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India Published in Viruses
MDPI, Switzerland
20 SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters Published in Viruses
MDPI, Switzerland
21 Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta in individuals sera vaccinated with BBV152 Published in International Society of Travel Medicine
22 Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin Published in Journal of Travel Medicine
Oxford University Press
23 Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021 Published in Journal of Infection
24 Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and Delta variant in India, 2021: A case-control study Preprint
25 ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection Published in Viruses
MDPI, Switzerland
26 An in vitro and in vivo approach for the isolation of Omicron variant from human clinical specimens Preprint bioRxiv
27 Persistence of immunity and impact of a third (booster) dose of an inactivated SARS-CoV-2 vaccine, BBV152; a phase 2, double-blind, randomised controlled trial Preprint medRxiv
28 Delta Variant SARS-CoV-2 infections in pediatric cases during the second wave in India Preprint medRxiv
29 Pathogenicity of SARS-CoV-2 Omicron in Syrian hamsters and its neutralization with different Variants of Concern Preprint bioRxiv
30 Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns Published in Journal of Infection
31 Detection of Zika virus disease in Thiruvananthapuram, Kerala, India 2021 during the second wave of COVID-19 pandemic Published in Journal of Medical Virology
32 Isolation and Genomic Characterization of SARS-CoV-2 Omicron Variant Obtained from Human Clinical Specimens Published in Viruses
MDPI, Switzerland
33 A case with SARS-CoV-2 reinfection from India Published in Indian Journal of Medical Microbiology
Elsevier
34 SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera Published in Journal of Infection
Elsevier
35 Detection and isolation of SARS-CoV-2 Eta variant from the international travelers and local residents of India Accepted in Journal of Medical Virology
36 Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters Published in Viruses
MDPI, Switzerland
37 Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021 Published in Journal of Infection
Elsevier
38 Development of a Reverse Transcription Loop - Mediated Isothermal Amplification [RT-LAMP] as a early rapid detection assay for Crimean Congo Hemorrhagic Fever virus Accepted in Science Direct
39 Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern Published in eBioMedicine
40 A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional Accepted in Journal of Infection
Elsevier
41 Reduced neutralizing antibody response in naive Covishield vaccinees against Omicron emphasizes booster vaccination Accepted in Journal of Infection
Elsevier
42 Isolation and characterization of SARS-CoV-2 Beta variant from UAE travelers Published in Journal of Infection and Public Health
Elsevier
43 SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model Accepted in Vector Borne & Zoonotic Diseases
Mary Ann Liebert, Inc. Publishers, USA
44 Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model Preprint bioRxiv
45 Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant Online Print Human Vaccines & Immunotherapeutics
46 Vaccination saves lives: A real-time study of patients with chronic diseases and severe COVID-19 infection Accepted in QJM: An International Journal of Medicine

Website Content Owned by
Indian Council of Medical Research, DHR, MoHFW, GoI

Website Hosted By :
National Informatics Centre